NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/07/2022
Voltar para busca
Dado oficial do USPTO
OXAPEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
57
Atualização mais recente
21/04/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
01/02/2018
Data de registro
12/07/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/07/2022
Última transação
21/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
SHEUNG WAN, HK
Examinador
NELMAN, JESSE M
Unidade examinadora
O20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
FIRST GAIN INTERNATIONAL LIMITED
Hong Kong Cytogenetics and Medical Genetics Centre Limited
Representantes
Timothy T. Wang NI, WANG & MASSAND, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Human and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorderstissue hypoxiashock and anemia; Human and veterinary pharmaceutical preparations to increase plasma oxygen content; biological preparations for medical and veterinary purposessterile solutions for use in oxygen therapeutics for the treatment of cardiovascular disorderstissue hypoxiashockanemiaGastrointestinal and Hepatobiliary System diseaseCardiovascular and Hematopoietic System diseasesRespiratory System diseasesCentral Nervous System diseasesMusculo-Skeletal System diseasesHormones related diseasesOncology diseasesGenito-Urinary System diseasesEndocrine and Metabolic System diseasesEye diseasesEar and Mouth or Throat diseasesSkin diseasesAllergy and Immune System diseases; biological preparations for medical and veterinary purposeshemoglobin solution for pharmaceutical purpose and intravenous infusion solutions of a synthetic colloids and crystalloids all for the treatment of cardiovascular disorderstissue hypoxiashockanemiaGastrointestinal and Hepatobiliary System diseaseCardiovascular and Hematopoietic System diseasesRespiratory System diseasesCentral Nervous System diseasesMusculo-Skeletal System diseasesHormones related diseasesOncology diseasesGenito-Urinary System diseasesEndocrine and Metabolic System diseasesEye diseasesEar and Mouth or Throat diseasesSkin diseasesAllergy and Immune System diseases; Biological preparations for medical and veterinary purposesprotein arraysbiological tissue culturesbloodblood plasmablood serums for the treatment of cardiovascular disorderstissue hypoxiashockanemiaGastrointestinal and Hepatobiliary System diseaseCardiovascular and Hematopoietic System diseasesRespiratory System diseasesCentral Nervous System diseasesMusculo-Skeletal System diseasesHormones related diseasesOncology diseasesGenito-Urinary System diseasesEndocrine and Metabolic System diseasesEye diseasesEar and Mouth or Throat diseasesSkin diseasesAllergy and Immune System diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
57 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
12/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/04/2022
PUBO
PUBLISHED FOR OPPOSITION
26/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/04/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/03/2022
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
09/03/2022
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
09/03/2022
APET
ASSIGNED TO PETITION STAFF
07/03/2022
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
25/02/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/02/2022
EX5G
SOU EXTENSION 5 GRANTED
17/02/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
17/02/2022
EXT5
SOU EXTENSION 5 FILED
10/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/02/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/08/2021
EX4G
SOU EXTENSION 4 GRANTED
23/08/2021
EXT4
SOU EXTENSION 4 FILED
23/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
23/08/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20/02/2021
EX3G
SOU EXTENSION 3 GRANTED
18/02/2021
EXT3
SOU EXTENSION 3 FILED
18/02/2021
EEXT
SOU TEAS EXTENSION RECEIVED
18/02/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15/08/2020
EX2G
SOU EXTENSION 2 GRANTED
13/08/2020
EXT2
SOU EXTENSION 2 FILED
13/08/2020
EEXT
SOU TEAS EXTENSION RECEIVED
13/08/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27/02/2020
EX1G
SOU EXTENSION 1 GRANTED
25/02/2020
EXT1
SOU EXTENSION 1 FILED
25/02/2020
EEXT
SOU TEAS EXTENSION RECEIVED
25/02/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/09/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2019
PUBO
PUBLISHED FOR OPPOSITION
09/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
06/06/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/06/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
06/06/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/06/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
30/05/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
20/02/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
20/11/2018
GNSL
LETTER OF SUSPENSION E-MAILED
20/11/2018
CNSL
SUSPENSION LETTER WRITTEN
20/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/11/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/11/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/05/2018
GNRT
NON-FINAL ACTION E-MAILED
15/05/2018
CNRT
NON-FINAL ACTION WRITTEN
15/05/2018
DOCK
ASSIGNED TO EXAMINER
15/05/2018
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
07/03/2018
ALIE
ASSIGNED TO LIE
05/03/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
20/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/02/2018
NWAP
NEW APPLICATION ENTERED
05/02/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OXAPEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.